98%
921
2 minutes
20
Objective: To observe the effect of transcutaneous auricular vagus nerve stimulation (taVNS) on the depressive behavior in depression rats, so as to explore its mechanism underlying improvement of depression.
Methods: A total of 24 male Sprague Dawley rats were randomly divided into normal, depression model, taVNS, tnVNS (transcutaneous auricular none-vagus nerve stimulaton) groups (=6 in each group). The depression model was established by chronic unpredictable mild stimulation combined with solitary raising for 35 consecutive days. After 14 days modeling, transcutaneous electrostimulation (2 mA, 2 Hz/15 Hz) was applied to auricular concha or auricular margin, respectively. Each intervention was conducted for 30 minutes, once daily for 21 days. The depression-like behavior was evaluated by forced swimming immobility time and body weight. The expression levels of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and interleukin-18 (IL-18) protein in the prefrontal cortex were detected by Western blot.
Results: Following modeling, the increase amount of body weight was decreased, the forced swimming immobility time and expression TLR4, MyD88 and IL-18 protein in the prefrontal cortex were increased in the model group than those in the normal group (<0.01). Following the treatment and compared with the model group, the increase amount of body weight in the taVNS group was obviously increased (<0.05), the swimming immobility time and the expression of TLR4, MyD88, IL-18 protein in the taVNS and tnVNS groups were significantly decreased (<0.01).
Conclusion: TaVNS is able to improve depression in depression rats, which is probably related to its effect in inhibiting inflammatory response of TLR4/MyD88 signaling pathway in prefrontal cortex.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.13702/j.1000-0607.20210180 | DOI Listing |
Cogn Affect Behav Neurosci
September 2025
Department of Behavioral and Cognitive Sciences, University of Luxembourg, Belval, 2, avenue de l'Universite, L- 4365, Esch sur-Alzette, Luxembourg.
Transcutaneous auricular vagus nerve stimulation (taVNS) affects autonomic function and enhances cognitive performance by increasing vagal activation and central noradrenergic activity. Nevertheless, the impact of taVNS on acute mental stress remains largely unexplored. This study examined whether taVNS can mitigate the acute sympathetic stress response and improve cognitive performance during a socially evaluated version of the Paced Auditory Serial Addition Task (PASAT).
View Article and Find Full Text PDFInt J Surg
September 2025
Division of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Background: Functional dyspepsia (FD) is often comorbid with sleep disturbance. Transcutaneous auricular vagal nerve stimulation (taVNS) is a new and non-invasive therapeutic option. This study aimed to investigate its effects and possible mechanisms on FD with sleep disturbance.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Department of Anesthesiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Importance: Postpartum uterine contraction pain manifests as a severe, intermittent lower abdominal discomfort caused by uterine contraction during the early puerperium. Transcutaneous auricular vagus nerve stimulation (taVNS) has demonstrated promising effects in managing both acute and chronic pain conditions; however, there remains a paucity of studies regarding the use of taVNS for alleviating postpartum uterine contraction pain.
Objective: To investigate the effect of taVNS in alleviating postpartum uterine contraction pain among women receiving combined spinal-epidural anesthesia for elective cesarean delivery.
J Transl Gastroenterol
June 2025
Transtimulation Research Inc., Oklahoma, OK, USA.
Imbalanced autonomic function has been reported in gastrointestinal (GI) disorders. The vagus nerve is a major component in the regulation of upper GI motility. Vagal nerve stimulation (VNS) has been shown to improve symptoms of various GI disorders by enhancing parasympathetic activity.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Department of Anesthesiology and Clinical Research Center for Anesthesia and Perioperative Medicine and Key Laboratory of Anesthesia and Analgesia Application Technology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China.
Background: Partial hepatectomy remains a primary therapeutic intervention for various hepatic diseases. However, several intraoperative factors, including surgical manipulation, substantial blood loss, the need for blood transfusions, and hypoxic stress, can significantly impair liver function. Current perioperative strategies aimed at protecting the liver exhibit certain limitations.
View Article and Find Full Text PDF